• 한국가금학회지
• /
• 제12권2호
• /
• pp.89-95
• /
• 1985

항생제인 Spiramycin과 Virginiamycin의 성장촉진 효과를 측정하기 위하여 총 360수의 육용계 (broiler chicken) 초생추를 battery에 수용하여 각각 6주씩 2차에 걸친 사양시험과 4일간의 대사시험을 실시하였다. 1차 실험에서는 고단백(21.9%), 고열량( 3159kca1/kg) 사료를 사용하였으며 180수의 숫병아리를 10수씩 무첨가구 Spiramycin(5ppm)구 및 Virginiamycin(5ppm)구에 각각 6반복씩 완전임의 배치하였다. 2차실험에서는 중단백( 19,95%), 중열량(2931 kca1/kg) 사료를 사용하고 90수의 숫병아리와 90수의 암병아리를 10수씩 분리하여 처리당 암ㆍ수 각각 3 반복씩 배치하였다. 사양시험을 통하여 얻어진 증체량, 사료섭취량, 사료효율 및 폐사율은 처리구간에 통계적 유의차가 없었으나 1, 2차 실험 공히 항생제 B구가 무처리구(1차실험) 또는 항생제 A구(2차실험) 보다 약 3% 높은 증체량을 나타내었다. 사료효율에 있어서도 항생제 B구가 가장 좋은 경향을 보여주었다. 2차실험의 결과에 의하면 증체량, 사료섭취량 및 사료효율에 있어서 암수간에는 유의한(p〈0.01) 차이가 있었다. 대사시험결과 항생제 B구가 타처리구보다 영양소 이용률이 높은 경향을 나타내었으며 특히 1차 실험에 있어서 조지방의 이용률은 타처리에 비해 유의하게 (p〈0.01) 높았고 조섬유이용률도 항생제 A구에 비해 유의하게 (p〈0.05) 높았다. 한편 대사체중당 소장의 무게와 길이는 항생제 B구가 타처리구에 비해 무겁고 긴 경향을 보여주었다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제10권2호
• /
• pp.178-184
• /
• 1997

Purified diets containing five graded levels of lysine were fed to a total of 125 growing chicks (25 chicks per treatment) to evaluate lysine requirements for growth and maintenance. A model was developed to separate lysine requirement for maintenance from requirement for growth. Based on weight gain response, the daily lysine requirement for growth was 12.06 mg/g gain and the daily lysine requirement for maintenance was 0.332 times metabolic body size ($W^{0.75}$). Similarly, the lysine requirement for growth was 0.457 mg/mg nitrogen gain and the daily lysine requirement for maintenance was 0.344 times metabolic body size. The plateau of plasma lysine concentration was reached at 354.75 mg intake/day. The total lysine requirement was 414.27 mg/day or 1.0% of the diet, 420.11 mg/day or 1.01% of the diet based on weight gain response and N gain response, respectively. Previous lysine requirements for growing chicks of 1-28 days old were in close agreement with these estimates. As a percentage of protein, lysine requirement was calculated to be 7.3% and the reported lysine content of chick muscle crude protein of 7.46% was closely related.

• Journal of Nutrition and Health
• /
• 제27권5호
• /
• pp.451-459
• /
• 1994

This study was performed to investigate the effect of sources of protein on iron bioavailability in 10 healthy young Korean women. The 18-day metabolic study consisted of a 6-day adaptation period, 6-day moderate protein(60g protein/day, 18mg Fe/day) and 6-day high protein period(90g protein/day, 18mg Fe/day). During the moderate and high protein period, 5 subjects were fed the high plant protein meals(80% plant protein). Fecal excretion of dietary iron was significantly higher(p<0.05) in high protein high plant diet group(HPP, 9.48$\pm$1.61mg/day) than in high protein high animal diet group (HPA, 14.40$\pm$0.89mg/day). Apparent absorption and bioavailability of iron was also significantly higher(p<0.10) in HPA(40.7$\pm$5.3%, 6.46$\pm$1.61mg/day) than in HPP(14.4$\pm$5.3%, 2.39$\pm$0.89mg/day). But there was no significant difference between the high animal protein group and high plant protein group in moderate protein period. Serum iron concentration and transferrin saturation increased as animal protein intake increased, from 106.0$\pm$5.1ug/이 and 30.6$\pm$1.5% for MPA to 129.1$\pm$6.7ug/이 and 37.1$\pm$1.3% for HPA. Statistically positive correlations were shown not only between the level of dietary heme iron and apparent absorption(r=0.95, p<0.05), but also between serum iron concentration and apparent absorption(r=0.64, p<0.05). Negative iron balance was shown in two subjects fed the moderate protein meals. These results suggest that recommanded dietary allowances of iron may be under the need to maintain the positive balance, and iron bioavaliability increase by only high level of animal protein intake.

• Journal of Nutrition and Health
• /
• 제35권9호
• /
• pp.932-942
• /
• 2002

In order to observe the effects of resistant starches on the physio-nutrition in women, nine female university students were investigated using cellulose (CED), resistant starch 3 (RS3D) and resistant starch 4 (RS4D) diets. Each woman's daily intake and excretions of energy, protein and lipid were mesured together with the apparent digestibility and the amounts of total cholesterol and HDL-cholesterol were measured. The results obtained from this researh are as follows. The daily energy intake were significantly higher in the RS4D (Resistant starch 4 diet) compared with the CED(Cellulose) and the RS3D (Resistant starch 3 diet). The metabolic energy in those periods with RS added to their diets were significantly higher whereas the metabolic energy in the period CED was significantly low. The daily protein intake was significantly higher in the RS4D compared with the CED and the RS3D. The apparent digestibility of protein was significantly higher in the RS4D compared with the CED and the RS3D. The daily lipid intake was significantly higher in the CED compared with the RS3D and the RS4D. The apparent digestibility of lipid was not significant in that period. The concentration of total cholesterol, HDL-cholesterol, % of HDL-cholesterol and atherogenic index (A.I.) were not significant in those period. As the above results indicate, while RS3 appear to have similar effect on energy consumption rate, apparent protein digestibility and content of cholesterol in plasma, compared with the CED, but energy consumption rate and apparent digestibility of protein are significantly higher in the RS4D compared with the CED. Thus, it appears that cellulose and RS 3 share similar effects on physio-nutrition in human, while RS4 does not have the similar effects. (Korean J Nutrition 35(9) : 932∼942, 2002)

• Nutrition Research and Practice
• /
• 제10권3호
• /
• pp.328-335
• /
• 2016

BACKGROUND/OBJECTIVES: Vitamin D plays an important role in the etiology of gestational diabetes mellitus (GDM). This study evaluated the effect of vitamin D supplementation on metabolic indices and hs-C-reactive protein (CRP) levels in GDM patients. SUBJECTS/METHODS: The study was a randomized, placebo-controlled, double-blinded clinical trial. Seventy-six pregnant women with GDM and gestational age between 24-28 weeks were assigned to receive four oral treatments consisting of 50,000 IU of vitamin $D_3$ (n = 38) or placebo (n = 38) once every 2 weeks for 2 months. Fasting blood glucose (FG), insulin, HbA1c, 25-hydroxyvitamin D, lipid profile, hs-CRP, and homeostasis model assessment-insulin resistance (HOMA-IR) were measured before and after treatment. Independent and paired t-tests were used to determine intra- and intergroup differences, respectively. ANCOVA was used to assess the effects of vitamin D supplementation on biochemical parameters. RESULTS: Compared with the placebo group, in the vitamin D group, the serum level of 25-hydroxyvitamin D increased (19.15 vs. -0.40 ng/ml; P < 0.01) and that of FG (-4.72 vs. 5.27 mg/dl; P = 0.01) as well as HbA1c (-0.18% vs. 0.17%; P = 0.02) decreased. Improvements in the lipid profiles were observed in the vitamin D group, but without statistical significance. Significant increases in concentrations of hs-CRP, FG, HbA1c, total cholesterol, and LDL cholesterol were observed in the placebo group. No significant change in fasting insulin and HOMA-IR was observed in either group. CONCLUSIONS: In GDM patients, vitamin D supplementation improved FG and HbA1c but had no significant effects on lipid profile or hs-CRP.

• 대한유전성대사질환학회지
• /
• 제13권1호
• /
• pp.48-53
• /
• 2013

Tyrosinemia I (fumarylacetoacetate hydrolase deficiency) is an autosomal recessive inborn error of tyrosine metabolism that produces liver failure in infancy or a more chronic course of liver disease with cirrhosis, often complicated by hepatocellular carcinoma in childhood or early adolescence. We studied a 37-year-old woman with tyrosinemia I whose severe liver disease in infancy and rickets during childhood were resolved with dietary therapy. From 14 years of age, she resumed unrestricted diet with the continued presence of the biochemical features of tyrosinemia, yet maintained normal liver function. In adult years, she accumulated only a small amount of succinylacetone. Despite this evolution to a mild biochemical and clinical phenotype, she eventually developed hepatocellular carcinoma. Her fumarylacetoacetate hydrolase genotype consists of a splice mutation, IVS6-1G>T, and a novel missense mutation, p.Q279R. Studies of resected liver revealed the absence of hydrolytic activity and immunological expression of fumarylacetoacetate hydrolase in tumour. In the non-tumoral areas, however, 53% of normal hydrolytic activity and immunologically present fumarylacetoacetate hydrolase were found. This case demonstrates the high risk of liver cancer in tyrosinemia I even in a seemingly favorable biological environment. In this study of tyrosinemia I, Case 2 with negative succinylacetone accumulation and the recovery of acute liver failure was compared with Case 1. Diet restriction and NTBC treatment are crucial to prevent hepatocellular carcinoma until liver transplant can take place and cure the condition. Further studies are needed to examine cases where liver cancer did not result despite clinical symptoms/signs of tyrosinemia type I.

• 대한유전성대사질환학회지
• /
• 제2권1호
• /
• pp.89-94
• /
• 2002

목 적 : 한국에서 처음 개발된 페닐케톤뇨증 소아를 위한 특수분유를 1년간 섭취시켜 발달양상 및 치료결과를 관찰하여 효율성과 안정성을 확인하고자 하였다. 방 법 : 순천향대학병원에서 페닐케톤뇨증으로 진찰된 소아 14명을 대상으로 1년간 수유하면서 식이 일기 평가, 혈장 아미노산 분석, 일반혈액검사, ferritin, 간기능검사, 소변검사를 시행하였다. 결 과 : 14명 모두 잘 먹었으며 신장, 체중, 두위는 모두 정상발육을 보였다. 혈색소는 모두 정상범위였다. 14례중 4례에서 ferritin 치가 12 ng/mL 이하여서 철분체제를 투여하였다. 알부민 치, S-GOT, S-GPT 소변검사는 모두 정상이었다. 페닐알라닌 치는 0.7-15.6 mg/dL로 대부분 정상 범위로 잘 유지되었다. 발진, 설사, 변비 등의 부작용은 관찰되지 않았다. 결 론 : 국내에서 처음 개발된 PKU-1과 PKU-2 Formula의 발육양상과 치료 결과가 좋은 것으로 확인되어 환자에게 안심하고 사용할 수 있는 우수한 제품으로 사료된다.

• Journal of Animal Science and Technology
• /
• 제63권5호
• /
• pp.1142-1158
• /
• 2021

Short-chain fatty acids (SCFAs) are metabolic products produced during the microbial fermentation of non-digestible fibers and play an important role in metabolic homeostasis and overall gut health. In this study, we investigated the effects of supplementation with multispecies probiotics (MSPs) containing Bacillus amyloliquefaciens, Limosilactobacillus reuteri, and Levilactobacillus brevis on the gut microbiota, and fecal SCFAs and lactate levels of weaned pigs. A total of 38 pigs weaned at 4 weeks of age were fed either a basal diet or a diet supplemented with MSPs for 6 weeks. MSP administration significantly increased the fecal concentrations of lactate (2.3-fold; p < 0.01), acetate (1.8-fold; p < 0.05), and formate (1.4-fold; p < 0.05). Moreover, MSP supplementation altered the gut microbiota of the pigs by significantly increasing the population of potentially beneficial bacteria such as Olsenella, Catonella, Catenibacterium, Acidaminococcus, and Ruminococcaceae. MSP supplementation also decreased the abundance of pathogenic bacteria such as Escherichia and Chlamydia. The modulation of the gut microbiota was observed to be strongly correlated with the changes in fecal SCFAs and lactate levels. Furthermore, we found changes in the functional pathways present within the gut, which supports our findings that MSP modulates the gut microbiota and SCFAs levels in pigs. The results support the potential use of MSPs to improve the gut health of animals by modulating SCFAs production.

• 한국응용과학기술학회지
• /
• 제36권1호
• /
• pp.34-46
• /
• 2019

비만은 대사증후군과 밀접한 관련이 있다. 본 연구는 8주간 고지방식이를 섭취한 쥐에서 고지혈증 치료제인 피노피브레이트(fenofibrate) 단독처방, 수영운동 단독처방 및 fenofibrate와 수영운동의 병합처방이 비만을 조절하는지를 조사하고, fenofibrate와 수영운동의 병합처방이 fenofibrate 단독처방에 비해 효과적으로 비만을 조절하는지를 분석하였다. Fenofibrate 단독처방과 수영운동 단독처방 모두 대조군에 비해 비만과 관련된 요소들인 몸무게, 지방무게, 혈청 지질성분 및 지방세포 크기를 감소시켰다. 쥐는 fenofibrate와 수영운동의 병합처방 되었을 경우 fenofibrate 단독처방 되었을 경우에 비해 비만과 관련된 요소들이 더 효과적으로 감소되었다. 대조군에 비해 fenofibrate 단독처방, 수영운동 단독처방 및 fenofibrate와 수영운동의 병합처방 모두 혈청 포도당 수치를 감소시켰다. 본 연구는 fenofibrate와 수영운동의 병합처방이 비만과 혈당을 효과적으로 조절함으로써 고지방식이 섭취로 인해 발생되는 대사증후군의 억제에 공헌할 것임을 제시하고 있다.

• Biomolecules & Therapeutics
• /
• 제27권2호
• /
• pp.134-144
• /
• 2019

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased with the incidence of obesity; however, the underlying mechanisms are unknown. In this study, high-resolution metabolomics (HRM) along with transcriptomics were applied on animal models to draw a mechanistic insight of NAFLD. Wild type (WT) and catalase knockout (CKO) mice were fed with normal fat diet (NFD) or high fat diet (HFD) to identify the changes in metabolic and transcriptomic profiles caused by catalase gene deletion in correspondence with HFD. Integrated omics analysis revealed that cholic acid and $3{\beta}$, $7{\alpha}$-dihydroxy-5-cholestenoate along with cyp7b1 gene involved in primary bile acid biosynthesis were strongly affected by HFD. The analysis also showed that CKO significantly changed all-trans-5,6-epoxy-retinoic acid or all-trans-4-hydroxy-retinoic acid and all-trans-4-oxo-retinoic acid along with cyp3a41b gene in retinol metabolism, and ${\alpha}/{\gamma}$-linolenic acid, eicosapentaenoic acid and thromboxane A2 along with ptgs1 and tbxas1 genes in linolenic acid metabolism. Our results suggest that dysregulated primary bile acid biosynthesis may contribute to liver steatohepatitis, while up-regulated retinol metabolism and linolenic acid metabolism may have contributed to oxidative stress and inflammatory phenomena in our NAFLD model created using CKO mice fed with HFD.